Previous studies have indicated that curculigoside can alleviate RA symptoms by downregulating inflammation-related signaling pathways, such as NF-кB/NLRP3 [21] and JAK/STAT/NF-κB [22]. This evidence concerns the gene SOAT1 and rheumatoid arthritis.